Materials & Resources » Chemicals | Skinvisible Inc.

Skinvisible Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,343.40
1,926.30
1,990.20
2,050.80
1,826.80
158.30
Depreciation, Depletion & Amortization
37.20
40.40
58.00
57.60
54.40
39
Other Funds
5.80
-
-
-
-
1,272.50
Funds from Operations
992.00
1,485.50
1,510.60
1,260.00
727.30
1,075.20
Changes in Working Capital
240.40
317.80
657.80
1,015.60
713.40
1,040.90
Net Operating Cash Flow
751.70
1,167.70
852.70
244.40
13.90
34.30
Capital Expenditures
106.10
71.20
5.70
-
15.00
Purchase/Sale of Investments
-
-
-
-
32.30
Net Investing Cash Flow
106.10
71.20
5.70
-
47.30
Issuance/Reduction of Debt, Net
926.50
922.10
581.90
172.40
81.50
Net Financing Cash Flow
920.70
922.10
661.90
247.40
81.50
Net Change in Cash
62.90
316.80
196.60
3.00
20.30
Free Cash Flow
857.80
1,238.90
858.50
244.40
28.90
Change in Capital Stock
-
-
80.00
75.00
-

About Skinvisible

View Profile
Address
6320 South Sandhill Road
Las Vegas Nevada 89120
United States
Employees -
Website http://www.skinvisible.com
Updated 07/08/2019
company. The company develops a polymer delivery system, Invisicare and formulated skin products through its subsidiary. It develops topical prescription and over-the-counter products enhanced with Invisicare to license to pharmaceutical and consumer goods companies around the world for an upfront fee and ongoing royalties.